Rezultati pretraživanja
  1. prije 38 minuta

    #2020 promises to be a pivotal year for the rise of in . We are taking concrete steps towards making Quebec an authority in the sector. Learn more:

    1 korisnik označava da mu se sviđa
  2. prije 31 minutu

    What Clinical Research Could Look Like With Patient-Centric Trials.

  3. prije 37 minuta

    is beginning to transform the historically tortuous and expensive process of bringing a new drug to the clinic.

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
  4. prije 1 sat

    Encouraging engagement and involvement in helps facilitate the evaluation and introduction of new cancer medicines and modes of treatments for . Read about advances in Scotland over the last year.

    1 proslijeđeni tweet 5 korisnika označava da im se sviđa
  5. prije 22 minute

    Can you recommend anyone for this job in , ZH?

  6. prije 54 minute

    Attending this week? We'd love to meet you! Stop by the Greenphire booth to learn how our commitment to is easing site and participant burdens.

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  7. prije 2 sata

    Stop staring at the clock every day. It's time for a new career. Follow us to view jobs with titles like "Sr Clin Res Assoc II" in .

  8. prije 2 sata

    If you're looking for work in , Vienna, check out this job via the link in our bio: CRA II dedicated to Sponsor at Covance

  9. prije 3 sata

    We're hiring! Read about our latest job opening here: Senior CRA - sponsor dedicated - , WC

  10. prije 4 sata

    Dysmech Clinical Services Pvt ltd offers a 6-month Diploma program in and with hands-on software training in Argus/ ARISg/ MedDRA in association with Drug Information with assured placement support all over India.

  11. prije 20 sati

    Are you heading to the 5th European Conference on Clinical Research to catch up on current topics in science, technology, and regulations? Take a moment to schedule time with Olivier Simon and discover how Altasciences can help you advance your program.

  12. prije 21 sat

    Investigative sites now have access to a free 21 CFR Part 11 compliant eRegulatory solution to simplify compliance and speed study startup. Read more in this ACRP blog:

    2 korisnika označavaju da im se sviđa
  13. prije 22 sata

    CROs play a key role in patient safety and satisfaction during . Today, we're celebrating clinical trial participants and their contribution to drug development.

  14. prije 22 sata

    This is the new ACTide booth with a led lighted panel! Now you can recognize us even better at the events. We welcome you at EUCROF in Amsterdam at stand no 6. See you next week.

    1 reply 1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  15. 3. velj

    Are participants a true representative of our population

    3 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
  16. 3. velj

    See our latest , Community of Madrid job opportunity and click the link in our bio to apply: CRA II / SENIOR CRA I, MADRID-BARCELONA at Covance

  17. 31. sij

    Sign of a gr8 event is when I completely forget to take any photos with anyone cos I’m so immersed in the conversations & discussions. So this was all I got from today! 😂

    11 korisnika označava da im se sviđa
  18. 31. sij

    . and have just sent 270 questionnaires to diagnostic labs in 42 European countries assessing their capacity to detect . Preparing for .

    15 proslijeđenih tweetova 29 korisnika označava da im se sviđa
  19. 31. sij

    Identify activities that bring high value – financial and otherwise – to your . Learn more at a CTTI webinar 2/27:

    2 proslijeđena tweeta 5 korisnika označava da im se sviđa
  20. 31. sij

    How to Optimize Patient Enrollment and Recruitment.

    3 proslijeđena tweeta 5 korisnika označava da im se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.